Table 3: Summary of measures and univariate analysis of age, disease duration, body mass, function and arthritis impact by cardiovascular status (Mean ± SE) [CI].

Variable No Cardiovascular Disease N=6 Cardiovascular Disease N=11  P
Age (years) 69.5+2.4 [63.3-75.7] 71.5+2.5 [65.8-77.1] 0.62
Disease duration (years) 13.3 ± 3.7 [3.9-22.8] 11.9 ± 3.9 [3.1-20.7] 0.81
AIMS Physical Score (0-10) 4.7 ± 0.7 [2.95-6.4] 5.8 ± 0.7 [4.18-7.5] 0.32
AIMS Pain (0-6) 4.6 ± 0.7 [2.7-6.5] 4.6 ± 0.6 [3.4-5.9] 0.95
AIMS Impact Score (0-10) 3.8 ± 1.1 [0.99-6.5] 3.9 ± 0.8 [2.12-5.6] 0.93
Visual analogue pain score (0-10) 4.8 ± 1.7 [0.56-9.1] 4.4 ± 0.8 [2.7-6.2] 0.80
CES-D 6.3 ± 1.1 [3.6-9.04] 11.6 ± 2.4 [6.1-16.98] 0 .15
BMI (h.w-2) 29.8 ± 1.4 [26.4-33.3] 26.9 ± 0.6 [25.5-28.3] 0.03*
Pain Self Efficacy (10-100) 78.3 ± 6.1 [62.7-94.0] 69.1 ± 6.0 [55.7-82.5]  0.34
Symptoms Self Efficacy (10-100) 84.0 ± 9.1 [60.7-107.3] 71.9 ± 5.8 [59.1-84.8] 0.26
Self paced velocity (m) 48.5 ± 5.1 [35.3-61.9] 49.2 ± 5.3 [37.4-61.0] 0.97
Fast paced Walking Velocity (m.s-1) 54.2 ± 5.9 [39.1-69.4] 53.8 ± 5.3 [41.9-65.6]  0.93
6 min Walking Distance (m) 321.7+49.3 [195.0-448.7] 366.2 ± 38.6 [280.3-452.2 0.49
Perceived Exertion (0-15) * < 0.05 11.3 ± 0.7 [9.5-13.2] 11.6 ± 0.5 [10.5-12.6]  0.81

* < 0.05.